CH652304A5 - Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose. - Google Patents
Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose. Download PDFInfo
- Publication number
- CH652304A5 CH652304A5 CH5245/82A CH524582A CH652304A5 CH 652304 A5 CH652304 A5 CH 652304A5 CH 5245/82 A CH5245/82 A CH 5245/82A CH 524582 A CH524582 A CH 524582A CH 652304 A5 CH652304 A5 CH 652304A5
- Authority
- CH
- Switzerland
- Prior art keywords
- pharmaceutical composition
- ranitidine
- salt
- composition according
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8126786 | 1981-09-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH652304A5 true CH652304A5 (fr) | 1985-11-15 |
Family
ID=10524316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH5245/82A CH652304A5 (fr) | 1981-09-04 | 1982-09-03 | Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose. |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5865215A (it) |
| AU (1) | AU564018B2 (it) |
| BE (1) | BE894285A (it) |
| CH (1) | CH652304A5 (it) |
| DE (1) | DE3232830C2 (it) |
| FR (1) | FR2512342B1 (it) |
| HK (1) | HK91387A (it) |
| IE (1) | IE54149B1 (it) |
| IT (1) | IT1208432B (it) |
| KE (1) | KE3739A (it) |
| MY (1) | MY8700560A (it) |
| NL (1) | NL193821C (it) |
| SE (1) | SE8205034L (it) |
| SG (1) | SG59387G (it) |
| ZA (1) | ZA826477B (it) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
| JPH01197444A (ja) * | 1986-03-04 | 1989-08-09 | Bristol Myers Co | 非ステロイド系抗炎症組成物によって生じる消化管損傷に対するβ−アドレナリン作用薬とある種のヒスタミンＨ↓１−および／またはＨ↓２−受容体遮断薬との組合せの効果 |
| AU627775B2 (en) * | 1988-09-20 | 1992-09-03 | Glaxo Group Limited | Pharmaceutical compositions |
| EP1171161A1 (en) * | 1999-04-19 | 2002-01-16 | Richard Weisbart | Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2360306A1 (fr) * | 1976-08-03 | 1978-03-03 | Huguet Georgette | Nouveaux medicaments antalgiques, antiseptiques et anti-inflammatoires |
| GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
-
1982
- 1982-09-02 BE BE0/208936A patent/BE894285A/fr not_active IP Right Cessation
- 1982-09-03 NL NL8203457A patent/NL193821C/nl not_active IP Right Cessation
- 1982-09-03 IE IE2152/82A patent/IE54149B1/en not_active IP Right Cessation
- 1982-09-03 IT IT8249071A patent/IT1208432B/it active
- 1982-09-03 FR FR8215042A patent/FR2512342B1/fr not_active Expired
- 1982-09-03 ZA ZA826477A patent/ZA826477B/xx unknown
- 1982-09-03 DE DE3232830A patent/DE3232830C2/de not_active Expired - Lifetime
- 1982-09-03 JP JP57153791A patent/JPS5865215A/ja active Pending
- 1982-09-03 AU AU87997/82A patent/AU564018B2/en not_active Expired
- 1982-09-03 CH CH5245/82A patent/CH652304A5/fr not_active IP Right Cessation
- 1982-09-03 SE SE8205034A patent/SE8205034L/xx unknown
-
1987
- 1987-07-10 KE KE3739A patent/KE3739A/xx unknown
- 1987-07-22 SG SG593/87A patent/SG59387G/en unknown
- 1987-12-03 HK HK913/87A patent/HK91387A/xx not_active IP Right Cessation
- 1987-12-30 MY MY560/87A patent/MY8700560A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2512342B1 (fr) | 1986-09-05 |
| NL193821C (nl) | 2000-12-04 |
| DE3232830C2 (de) | 1994-12-08 |
| JPS5865215A (ja) | 1983-04-18 |
| IE822152L (en) | 1983-03-04 |
| ZA826477B (en) | 1984-04-25 |
| AU564018B2 (en) | 1987-07-30 |
| NL8203457A (nl) | 1983-04-05 |
| SE8205034D0 (sv) | 1982-09-03 |
| HK91387A (en) | 1987-12-11 |
| SE8205034L (sv) | 1983-03-05 |
| BE894285A (fr) | 1983-03-02 |
| FR2512342A1 (fr) | 1983-03-11 |
| IT8249071A0 (it) | 1982-09-03 |
| KE3739A (en) | 1987-09-04 |
| IE54149B1 (en) | 1989-07-05 |
| AU8799782A (en) | 1983-03-10 |
| SG59387G (en) | 1987-10-23 |
| IT1208432B (it) | 1989-06-12 |
| NL193821B (nl) | 2000-08-01 |
| DE3232830A1 (de) | 1983-03-24 |
| MY8700560A (en) | 1987-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2636532A1 (fr) | Compositions pharmaceutiques | |
| BE1007268A3 (fr) | Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie. | |
| GB2105193A (en) | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents | |
| CH679011A5 (it) | ||
| CH672068A5 (it) | ||
| FR2609632A1 (fr) | Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage | |
| CA2503211C (fr) | Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire | |
| FR2904774A1 (fr) | Composition pharmaceutique solide contenant une combinaison d'un agent regulateur de la motilite intestinale et d'un antiflatulent. | |
| BE1005115A5 (fr) | Compositions pharmaceutiques contenant des derives de furanne. | |
| EP1519753A1 (en) | Pharmaceutical combination of a thromboxane a2 receptor antagonist and a cox-2 inhibitor | |
| CH652304A5 (fr) | Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose. | |
| BE897058A (fr) | Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer | |
| CH679553A5 (it) | ||
| FR2512343A1 (fr) | Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition | |
| FR2627985A1 (fr) | Coadministration d'un medicament anti-inflammatoire non steroidique et de la sufotidine ou un de ses sels physiologiquement acceptables | |
| CH678149A5 (it) | ||
| LU85242A1 (fr) | Nouvelle association medicamenteuse | |
| FR2812547A1 (fr) | Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete | |
| FR2832064A1 (fr) | Composition pharmaceutique comprenant une glitazone et un derive de thiazolidinedione et son utilisation pour traiter le diabete | |
| FR2595048A1 (fr) | Composition pharmaceutique a base d'un derive de pyrimidine et ses applications therapeutiques | |
| FR2832930A1 (fr) | Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete | |
| LU84427A1 (fr) | A titre de medicaments,certains derives mono substitues de l'acide 4-phenyl 4-oxo buten-2-oique,ainsi que les compositions les renfermant | |
| FR2822069A1 (fr) | Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete | |
| FR2834640A1 (fr) | Composition pharmaceutique comprenant une glitazone et un acide 4-oxobutanoique et son utilisation pour traiter le diabete | |
| FR2585573A1 (fr) | Medicament pour prevenir l'abus d'alcool |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |